Skip to main content
Premium Trial:

Request an Annual Quote

Affy Shares Slide on Q4 Profit Decline, Q1 Outlook; Bank Downgrades Stock

NEW YORK, Jan. 27 (GenomeWeb News) - Affymetrix shares were down 6.97 percent, or $2.78, at $37.35 in afternoon trading after the company posted an 8.2-percent decline in fourth-quarter profits.


As GenomeWeb News reported, Affy's fourth-quarter profit fell to $24.8 million, or $0.35 per share, from $27.1 million, or $0.41 per share, during the fourth quarter of 2004.


The company also projected product and product-related revenue of $87 million for the first quarter of 2006, and total revenue of about $91 million, a 3-percent increase of total revenues for the first quarter of 2005.


Separately today Caris & Company downgraded the company to "average."

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.